AIIMS Patna starts human trial of Coronavirus vaccine

▴ AIIMS Patna starts human trial of Coronavirus vaccine
AIIMS Patna along with 12 other institutes starts human trial of Bharat Biotech's covid vaccine

In Bihar, AIIMS, Patna has started a human trial of Coronavirus vaccine on 10 volunteers selected by the hospital authority. Several people offered to take part in the trial, but only 10 people were selected for the process. The first dose has been given to selected people and after an interval of 14 days, the second dose will be given. Doctors are keeping strict vigil of those people who have taken a dose of vaccine. For this, a team of doctors has been constituted.

After completion of the scheduled period, a check-up of people will be undertaken for the after-effects of the vaccine. The vaccine jointly developed by the National Institute of Virology, Pune and Hyedrabad - based Bharat Biotech International Limited in collaboration with the Indian Council of Medical Research. It is the first indigenous vaccine developed in India.

AIIMS - Patna is one of the 12 medical institutes in the country to have been shortlisted by ICMR for conducting human trial of the indigenous vaccine .

Yesterday, cases in the state have risen to 17,421. Patients who have recovered are 12,364 while 4992 patients are undergoing treatment in hospitals. The recovery rate in Bihar stands at 71 percent. The state recorded 14 deaths for 24 hours including the first Coronavirus death of a doctor, taking the toll to 134.

Meanwhile, the total number of recovered people affected with coronavirus yesterday crossed the 5.5 lakh mark. The Central Government said, a total of 5, 53,471 people have recovered in the country so far and with this, the recovery rate reached 63.01 percent.

During the last 24 hours, 18,850 people have recovered from Covid-19. There are 19 States and Union Territories which have a higher recovery rate than the national average of recovery rate.

The Health and Family Welfare Ministry said a total of 28,701 new cases of Covid-19 have been reported in the country within 24 hours taking the total number of cases to 8,78,254. This is the highest number of fresh cases recorded in one day since the outbreak of the Covid-19 pandemic in India.

Presently, the total number of active corona cases in the country is 3,01,609. In a single day, 500 deaths have been reported taking the nationwide toll to 23,174. With this, the COVID fatality rate reached 2.63 percent in the country. 30 States and Union Territories have the lowest fatality rate than the national average of fatality rate.

Meanwhile, the Indian Council of Medical Research, ICMR said, that a total of 2,19,103 tests of coronavirus samples were conducted by the various laboratories in the country within 24 hours. So far 1,18,6,256 tests have been conducted. Testing per million is 8,555 in the country.

ICMR is continuously scaling up its testing facilities for Covid-19 by giving approval to government and private laboratories. As of now, a total of 1,200 laboratories across India has been given the approval to conduct the test for Covid-19 including 852 with another 12 institute government laboratories and 348 private laboratories' chains.

Tags : #AIIMSPatna #BharatBiotech #NationalInstituteofVirology #Pune #Hyderabad #PatnaCovidNews #ICMR

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Scientists in Moscow Develop Fetal Phantom for Obstetric UltrasoundNovember 19, 2024
International Men’s Day: A Celebration of Strength, Vulnerability, and ChangeNovember 19, 2024
The Bloody Truth: Why Menstruation Is Still a Taboo in Indian SchoolsNovember 19, 2024
Toxic Air, Fragile Hearts: The Hidden Cost of Pollution on Heart Failure PatientsNovember 19, 2024
Government of Telangana Hosts the AI in Healthcare Summit – Road to BioAsia 2025November 18, 2024
In yet another groundbreaking medical milestone, Sarvodaya Hospital successfully performs India’s youngest cochlear implant on a 5- month old babyNovember 18, 2024
Sightsavers India in collaboration with AbbVie Therapeutics India Private Limited Hosted the 4th State-Level Consultation on ‘Prevention of Visual Impairment Caused by Glaucoma’November 16, 2024
Is Your Saree Hurting You? How Tight Waist Petticoats Could Trigger Skin CancerNovember 16, 2024
10 New-born Lives Lost: The Jhansi Hospital Fire That Shook India’s ConscienceNovember 16, 2024
Streax introduces revolutionary Shampoo Hair Colour in South India at accessible price point.November 15, 2024
The Silent Killer in Your Genes: Can Splicing Errors Unlock New Cancer Cures?November 15, 2024
Stress on a Schedule: What Your Gut Bacteria Know That You Don’tNovember 15, 2024
A Preventable Catastrophe: Why Are Children Still Dying from Measles?November 15, 2024
The University of Tasmania invites applications for Master of Marine and Antarctic ScienceNovember 14, 2024
ICMR’s Bold Bet: Can India’s Scientists Deliver World-First Health Breakthroughs?November 14, 2024
The Dark Reality Behind India’s Ayushman Bharat: Profits Before Patients?November 14, 2024
Not a Fan of Exercise? Here’s How Few Steps You Actually Need for Better HealthNovember 14, 2024
Shiprocket launches AI Powered Shiprocket Copilot to empower a Self-Reliant Digital Future for over 1,00,000+ Indian MSMEsNovember 13, 2024
AIIMS Darbhanga and More: Can PM Modi’s 12,000 Crore Investment Turn Bihar into India’s Next Growth Engine?November 13, 2024
Self-Made Survivor: How a Virologist Battled Breast Cancer with Her Own Lab-Grown VirusesNovember 13, 2024